Hormone replacement therapy and cardiovascular disease: benefits explained by research bias
DOI:
https://doi.org/10.18597/rcog.619Keywords:
Hormone replacement therapy, coronary heart disease, biasAbstract
Although until time very recently the benefit of the hormone replacement therapy was accepted to prevent the coronary heart disease in postmenopausal women, now there are recommendations against it, these are born from the first controlled clinical trial that is devoted to the topic. A possible explanation to the contradiction between the observational studies that supported the employment and the clinical trial that doesn't find the benefits, can be the inherent biases to the first ones. It is carried out a revision of some of the biases that have already been demonstrated.Author Biography
John Jairo Zuleta Tobón
References
Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professional from the American Heart Association. Circulation 2001;104:499-503.
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.
Grady D, Nanette KW, Herrington D, Khan S, Furberg C, Hunninghake D, et al. Postmenopausal hormone therapy increases risk for venouses thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-96.
Grondstein F, Manson J, Stampfer M. Postmenopausal hormone use and secondary prevention of coronary event in he nurses' health study. A prospective, observational study. Ann Intern Med 2001;135:1-8.
Pollner F. La WHI a medio camino. Orgyn 1998;4:33-5.
Lenfant C. Statement from Claude Lefant, MD. NHLBI Director, on preliminary trends in the Women's Health Initiative. Washington, DC: National Institutes of Health; April 3, 2000. En: Mendelsohn ME, Karas RH. The time has come to stop letting the HERS tale wag the dogma (editorial). Circulation 2001;104:2256-9.
Mendelsohn ME, Karas RH. The time has come to stop letting the HERS tale wag the dogma (editorial). Circulation 2001;104:2256-9.
Herrington DM: The HERS trial results: Paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Intern Med 1999;131:463-6.
Mathews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971-8.
Cauley JA, Cummings SR, Blach DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-44.
Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Hortwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990;336:542-5.
Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-6.
Sturgeon S, Schairer C, Brinton LA, Pearson T, Hoover R. Evidence of healthy estrogen user survivor effect. Epidemiology 1995;6:227-31.
Posthuma W, Westendorp RG, Vanderbrouche JP. Cardioprotective effect of hormone replacement therapy in posmenopausal women: is the evidence biased? BMJ 1994;308:1268-9.
Imperiale TF, Stollenwerk P. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266:260-4.
CLASP. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-29.
Grondstein F. Invited commentary: can selection bias explain the cardiovascular benefits of estrogen replacement therapy? Am J Epidemiol 1996;143:979-82.
Hemminki E, McPherson K. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ 1997;315:149-53.
Blakely JA. The heart and Estrogen/Progestin replacement study revisited: Hormone replacement therapy produced net harm, consistent with the observational data. Ann Intern Med 2000;160:2897-900.
Fletcher RH, Fletcher S, Wagner EH. Epidemiología clínica. Aspectos fundamentales. 2a. ed. Barcelona; 1998. p. 287
Rossouw JE. Estrogens for prevention of coronary heart disease. Putting the brakes on the bandwagon. Circulation 1996;94:2982-5.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Revista Colombiana de Obstetricia y Ginecología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
